After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Novavax, Inc is $1.27B. A total of 6.06 million shares were traded on the day, compared to an average of 4.19M shares.
Insider Activity
Insider trades can also provide insight into a stock’s future direction. During the recent three months, NVAX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, King Rachel K. sold 4,150 shares of NVAX for 9.02 per share on Dec 13 ’24. After the transaction, the Director now owns 14,770 company shares. In a previous transaction on Dec 31 ’24, YOUNG JAMES F sold 5,400 shares at 8.00 per share. NVAX shares that Director owns now total 51,760.
Among the insiders who sold shares, YOUNG JAMES F disposed of 4,600 shares on Dec 24 ’24 at a per-share price of $8.48. This resulted in the Director holding 57,160 shares of NVAX after the transaction. In another insider transaction, YOUNG JAMES F bought 10,000 shares at $8.48 per share on Dec 24 ’24.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for NVAX in the last 3 months, the mean price target is $16.43 with high estimates of $25.00 and low estimates of $9.00. In terms of 52-week highs and lows, NVAX has a high of $23.86 and a low of $3.81.
As of this writing, NVAX has an earnings estimate of -$0.38 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.25 per share and a lower estimate of -$0.46.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. NVAX’s latest balance sheet shows that the firm has $1.52B in Cash & Short Term Investments as of fiscal 2021. There were $453.99M in debt and $2.39B in liabilities at the time. Its Book Value Per Share was -$3.89, while its Total Shareholder’s Equity was -$351.67M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NVAX is Buy with a score of 3.86.
